Shan Dong Kexing Bioproducts Co Ltd
688136
Company Profile
Business description
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
Contact
No. 2666, Chuangye Road
Mingshui Development Zone
Zhangqiu District
Shandong Province
Jinan250200
CHNT: +86 75586967773
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,046
Stocks News & Analysis
stocks
Best and worst performing ASX sectors of 2024
Exploring the ASX sectors that moved the market this year.
stocks
2 ASX companies with the traits of a long-term winner
Two companies that show promising signs of handsomely rewarding shareholders.
video
Our outlook for 2025
Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,465.00 | 44.50 | 0.53% |
| CAC 40 | 7,386.95 | 6.21 | 0.08% |
| DAX 40 | 19,984.01 | 74.87 | 0.38% |
| Dow JONES (US) | 42,531.50 | 12.72 | -0.03% |
| FTSE 100 | 8,254.52 | 81.50 | 1.00% |
| HKSE | 19,623.32 | 436.63 | -2.18% |
| NASDAQ | 19,348.19 | 37.39 | 0.19% |
| Nikkei 225 | 39,894.54 | 386.62 | -0.96% |
| NZX 50 Index | 13,110.74 | 159.27 | -1.20% |
| S&P 500 | 5,888.70 | 7.07 | 0.12% |
| S&P/ASX 200 | 8,201.20 | 42.10 | 0.52% |
| SSE Composite Index | 3,262.56 | 89.20 | -2.66% |